[1]
“Impact of Deucravacitinib on Scalp Psoriasis in a Real-world Prospective Cohort Study in the United States”, J of Skin, vol. 9, no. 2, p. s536, Mar. 2025, doi: 10.25251/skin.10.supp.536.